home / United States / Cassava Sciences

Cassava Sciences Market Cap

$0.12 B

-1.44 M

NASDAQ:SAVA · January 22, 2025

Share price

$2.59

Enterprise Value

$-0.02 B

Change (1-Year)

-89.4%

Global Rank

#7521

Country Rank

#2977

Regions

USA

Market cap

As of January 22, 2025, Cassava Sciences (SAVA) has a market cap of $0.12 billion USD. According to our data, Cassava Sciences is ranked No.7521 in global market value.

Sector Rank:

Biotech #523 Diagnostics and Testing #36

SAVA Market Capitalization Growth

30D Growth:

17.5%

1 Years Growth:

-89.4%

3 Years Growth:

-93.0%

5 Years Growth:

-64.4%

10 Years Growth:

-79.9%

15 Years Growth:

-87.0%

20 Years Growth:

-89.7%

Total Growth:

-96%

Cassava Sciences Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Cassava Sciences Market Cap CAGR Chart

Cassava Sciences Market Cap History 2000 - 2025

Year	Market Cap	%Change
Jan 22, 2025	$0.12 B	9.75%
Dec 31, 2024	$0.11 B	-89.52%
Dec 29, 2023	$1.08 B	-23.80%
Dec 30, 2022	$1.42 B	-32.40%
Dec 31, 2021	$2.10 B	540.76%
Dec 31, 2020	$0.33 B	31.15%
Dec 31, 2019	$0.25 B	511.76%
Dec 31, 2018	$40.89 M	-78.75%
Dec 29, 2017	$0.19 B	0.25%
Dec 30, 2016	$0.19 B	-67.43%
Dec 31, 2015	$0.59 B	-13.79%
Dec 31, 2014	$0.68 B	-58.23%
Dec 31, 2013	$1.64 B	79.34%
Dec 31, 2012	$0.91 B	-6.76%
Dec 30, 2011	$0.98 B	-43.70%
Dec 31, 2010	$1.74 B	65.29%
Dec 31, 2009	$1.05 B	-9.46%
Dec 31, 2008	$1.16 B	-44.15%
Dec 31, 2007	$2.08 B	19.10%
Dec 29, 2006	$1.75 B	31.66%
Dec 30, 2005	$1.33 B	-6.24%
Dec 31, 2004	$1.42 B	3.74%
Dec 31, 2003	$1.36 B	190.80%
Dec 31, 2002	$0.47 B	-73.91%
Dec 31, 2001	$1.80 B	-38.42%
Dec 29, 2000	$2.92 B	100%

Similar Companies to Cassava Sciences

Name	Market Cap	Market cap difference	Regions
Biogen BIIB	$20.80 B	0.000 M	USA
Eli Lilly LLY	$678.07 B	0.022 M	USA
AC Immune ACIU	$0.27 B	-0.000 M	Switzerland
Anavex Life Sciences AVXL	$0.85 B	0.000 M	USA
Denali Therapeutics DNLI	$3.35 B	-0.000 M	USA
Prothena PRTA	$0.78 B	0.000 M	Ireland
BioXcel Therapeutics BTAI	$18.04 M	0.000 M	USA
Intra-Cellular Therapies ITCI	$13.51 B	-0.000 M	USA
Sage Therapeutics SAGE	$0.43 B	-0.000 M	USA
ACADIA Pharmaceuticals ACAD	$2.96 B	-0.000 M	USA
Alector ALEC	$0.17 B	0.000 M	USA

About Cassava Sciences Inc.

Name

Cassava Sciences, Inc.

Website

https://www.cassavasciences.com

Headquarters

Austin,TX

symbol

SAVA

CURRENCY

USD

country

United States

fullTimeEmployees

exchange

NCM

firstTradeDateEpochUtc

2000/07/14

SAVA Market Cap Formula

Market Cap	=	SAVA Stock Price	*	SAVA Shares Outstanding
	=	$2.59	*	48.11 M
	=	$0.12 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe